<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>366-MORPHINE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="MORPHINE" rxcui="7052">
<ATC code="A07DA52" />
<ATC code="N02AA01" />
<ATC code="N02AA51" />
<ATC code="N02AG01" />
<ATC code="R05DA05" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="RIFAMPICIN" rxcui="9384">
<ATC code="J04AB02" />
<ATC code="J04AM02" />
<ATC code="J04AM05" />
<ATC code="J04AM06" />
</DRUG>
</DRUG2>
<DESCRIPTION>Decrease of the plasma concentrations and of the effectiveness of the morphine and of its active metabolite</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Clinical monitoring and possible adjustment of the dosage of the morphine during the treatment with the rifampicin and after it is stopped. </COMMENT>
</INTERACTION>
</INTERACTIONS>
